• Tel: 858.663.9055
  • SeparatorEmail: info@nsjbio.com
  • Tel: 858.663.9055
  • Email: info@nsjbio.com
Home >> Antibodies >> SNCA Antibody / Alpha Synuclein

SNCA Antibody / Alpha Synuclein (FY12837)

  Catalog No Formulation Size Price (USD)  
Image FY12837 Adding 0.2 ml of distilled water will yield a concentration of 500 ug/ml 100 ug 439
Bulk quote request
Immunohistochemical staining of SNCA using anti-SNCA antibody. SNCA was detected in a paraffin-embedded section of mouse brain tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH 8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 ug/ml rabbit anti-SNCA antibody overnight at 4oC. Peroxidase Conjugated Goat Anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37oC. The tissue section was developed using an HRP secondary and DAB substrate.
Western blot analysis of SNCA using anti-SNCA antibody. Electrophoresis was performed on a 13% SDS-PAGE gel at 80V (Stacking gel) / 120V (Resolving gel) for 2 hours. Lane 1: rat brain tissue lysates, Lane 2: mouse brain tissue lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-SNCA antibody at 0.5 ug/ml overnight at 4oC, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal was developed using an ECL Plus Western Blotting Substrate. SNCA western blot of rat and mouse brain shows a predominant band at ~16-18 kDa, consistent with alpha-synuclein migrating above its predicted ~14.5 kDa due to its acidic, intrinsically disordered nature and common N-terminal acetylation.
Immunohistochemical staining of SNCA using anti-SNCA antibody. SNCA was detected in a paraffin-embedded section of human brain tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH 8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 ug/ml rabbit anti-SNCA antibody overnight at 4oC. Peroxidase Conjugated Goat Anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37oC. The tissue section was developed using an HRP secondary and DAB substrate.
Immunohistochemical staining of SNCA using anti-SNCA antibody. SNCA was detected in a paraffin-embedded section of rat brain tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH 8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 ug/ml rabbit anti-SNCA antibody overnight at 4oC. Peroxidase Conjugated Goat Anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37oC. The tissue section was developed using an HRP secondary and DAB substrate.
Immunofluorescent staining of SNCA using anti-SNCA antibody (green). SNCA was detected in an immunocytochemical section of SiHa cells. Enzyme antigen retrieval was performed using IHC enzyme antigen retrieval reagent for 15 mins. The cells were blocked with 10% goat serum. And then incubated with 5 ug/ml rabbit anti-SNCA antibody overnight at 4oC. DyLight 488 Conjugated Goat Anti-Rabbit IgG was used as secondary antibody at 1:500 dilution and incubated for 30 minutes at 37oC. The section was counterstained with DAPI nuclear stain (blue). Visualize using a fluorescence microscope and filter sets appropriate for the label used.
Flow Cytometry analysis of U87 cells using anti-SNCA antibody. Overlay histogram showing U87 cells stained with (Blue line). The cells were fixed with 4% paraformaldehyde and blocked with 10% normal goat serum. And then incubated with rabbit anti-SNCA antibody (1 ug/million cells) for 30 min at 20oC. DyLight 488 conjugated goat anti-rabbit IgG (5-10 ug/million cells) was used as secondary antibody for 30 minutes at 20oC. Isotype control antibody (Green line) was rabbit IgG (1 ug/million cells) used under the same conditions. Unlabelled sample without incubation with primary antibody and secondary antibody (Red line) was used as a blank control.
Immunohistochemical staining of SNCA using anti-SNCA antibody. SNCA was detected in a paraffin-embedded section of human brain tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH 8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 ug/ml rabbit anti-SNCA antibody overnight at 4oC. Peroxidase Conjugated Goat Anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37oC. The tissue section was developed using an HRP secondary and DAB substrate.
Availability 1-2 days
Species Reactivity Human, Mouse, Rat
Format Lyophilized
Clonality Polyclonal (rabbit origin)
Isotype Rabbit IgG
Purity Immunogen affinity purified
Buffer Each vial contains 4 mg Trehalose, 0.9 mg NaCl and 0.2 mg Na2HPO4.
UniProt P37840
Localization Cytoplasmic, Nuclear
Applications Western Blot : 0.25-0.5ug/ml
Immunohistochemistry : 2-5ug/ml
Immunocytochemistry : 5ug/ml
Immunofluorescence : 5ug/ml
Flow Cytometry : 1-3ug/million cells
ELISA : 0.1-0.5ug/ml
Limitations This SNCA antibody is available for research use only.
Review this product on BioCompare and get a $20 Amazon gift card

Related Products

Description

SNCA antibody detects Alpha-synuclein, a small neuronal protein central to synaptic regulation, vesicle trafficking, and neurodegenerative disease pathology. Encoded by the SNCA gene on chromosome 4q22.1, Alpha-synuclein is a 140-amino acid presynaptic protein that modulates neurotransmitter release, synaptic vesicle recycling, and membrane curvature. It is highly expressed in the central nervous system, particularly in presynaptic terminals of dopaminergic neurons, where it helps maintain synaptic homeostasis. Despite its physiological role in neurotransmission, misfolded or aggregated forms of Alpha-synuclein are strongly implicated in Parkinson's disease and other synucleinopathies.

Alpha-synuclein belongs to the synuclein family, which also includes Beta- and Gamma-synuclein. Structurally, it consists of three domains: an amphipathic N-terminal region that binds lipid membranes, a hydrophobic central non-amyloid-beta component (NAC) domain that promotes aggregation, and a highly acidic C-terminal region that interacts with synaptic vesicle components. These domains allow Alpha-synuclein to reversibly associate with synaptic vesicle membranes and regulate vesicle clustering, docking, and fusion events required for neurotransmitter release.

The SNCA antibody is widely used in neuroscience, neurodegenerative disease, and cellular biology research to study protein aggregation, synaptic function, and neuronal homeostasis. Western blot analysis identifies a 17 kilodalton band corresponding to Alpha-synuclein, while immunohistochemistry and immunofluorescence reveal diffuse cytoplasmic and presynaptic punctate staining in neurons. In pathological tissue, the antibody recognizes characteristic Lewy bodies and Lewy neurites formed by Alpha-synuclein aggregates, providing a valuable diagnostic marker for Parkinson's disease and dementia with Lewy bodies.

Physiologically, Alpha-synuclein interacts with SNARE complex proteins such as VAMP2 and synaptobrevin to facilitate vesicle fusion, while regulating dopamine release and synaptic plasticity. However, environmental stress, oxidative damage, or genetic mutations (e.g., A53T, A30P, E46K) can cause Alpha-synuclein misfolding and fibril formation. These aggregates trigger mitochondrial dysfunction, ER stress, and neuronal death through toxic oligomer formation. The SNCA antibody is an essential tool for studying these mechanisms and evaluating therapeutic interventions aimed at reducing aggregation or promoting clearance via autophagy and proteasomal degradation.

Alpha-synuclein also plays a role in non-neuronal systems, including erythrocytes and the enteric nervous system, where it may influence vesicular trafficking and lipid metabolism. Dysregulation of SNCA transcription and post-translational modifications such as phosphorylation (Ser129), nitration, or ubiquitination modulate its aggregation behavior and toxicity. The SNCA antibody supports high-resolution mapping of these biochemical changes, helping researchers understand disease progression and identify novel treatment strategies. NSJ Bioreagents validates this antibody for western blotting, immunohistochemistry, and immunofluorescence, ensuring reproducible and sensitive detection for neuroscience and neurodegenerative disease research.

Application Notes

Optimal dilution of the SNCA antibody should be determined by the researcher.

Immunogen

E.coli-derived human Alpha Synuclein/SNCA recombinant protein (Position: M1-D135) was used as the immunogen for the SNCA antibody.

Storage

After reconstitution, the SNCA antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Cross
Bulk Quote Request Form
Name*:
Organization*:
Email*:
Phone Number*:
Catalog No.*:
Comments and Specifics(amount, formulation, etc.)*:
Validation code: Captchapackage Image


Can't read the image? click here to refresh.
    *required field

Your bulk quote request has been submitted successfully!

Please contact us if you have any questions.